Vir Biotechnology, Inc. (VIR)
9.03
+0.15
(+1.69%)
USD |
NASDAQ |
May 21, 16:00
9.025
0.00 (0.00%)
After-Hours: 19:59
Vir Biotechnology Research and Development Expense (TTM) : 425.05M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 1.420B |
| BioMarin Pharmaceutical, Inc. | 721.03M |
| Krystal Biotech, Inc. | 54.64M |
| Gossamer Bio, Inc. | 179.10M |
| Sensei Biotherapeutics, Inc. | 13.28M |